Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Invitae CorpNVTA · Entity 95935 | Chief Accounting Officer | May 16, 2023 | May 18, 2023 |
| Twist Bioscience CorpTWST · Entity 3619 | Chief Accounting Officer | October 02, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Invitae Corp
Report date May 16, 2023 · Filed May 18, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 354,748 |
Reported balance
After 2023-05-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-05-16 · Sale · Disposed 21,559 · Balance 354,748 F1: Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units. F2: Represents a weighted average sale price. Actual sale prices ranged from $1.1993 to $1.1995 per share. The reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. F3: Includes 5,000 shares of common stock acquired under the Invitae Corporation Employee Stock Purchase Plan on May 15, 2023 and an aggregate of 286,469 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
F2: Represents a weighted average sale price. Actual sale prices ranged from $1.1993 to $1.1995 per share. The reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
F3: Includes 5,000 shares of common stock acquired under the Invitae Corporation Employee Stock Purchase Plan on May 15, 2023 and an aggregate of 286,469 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
Twist Bioscience Corp
Report date October 02, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,917 |
Reported balance
After 2026-10-02 transaction · row 1
1 source rowRow 1 · 2026-10-02 · Sale · Disposed 1,482 · Balance 42,917 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 5, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,482 | $188.88 | $279,926.09 |
DisclosureSEC source: 0001214659-26-012550 · marketforms-74098.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,917 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:00 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 238 | $122.62 | $29,184.51 |
DisclosureSEC source: 0001214659-26-011555 · marketforms-73973.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,399 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 24, 2026 Filed Aug 25, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 854 | $140.77 | $120,220.14 |
DisclosureSEC source: 0001214659-26-010827 · marketforms-73881.xml · nonDerivative · entry 2 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,637 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 21, 2026 Filed Aug 25, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 669 | $139.07 | $93,035.15 |
DisclosureSEC source: 0001214659-26-010827 · marketforms-73881.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,491 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 167 | $85.32 | $14,248.64 |
DisclosureSEC source: 0001214659-26-009654 · marketforms-73660.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,160 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GiftCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-007315 · marketforms-73370.xml · nonDerivative · entry 3 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,327 F2 · shares: Represents a bona fide gift of shares to a charitable organization. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,127 | $69.07 | $77,841.89 |
DisclosureSEC source: 0001214659-26-007315 · marketforms-73370.xml · nonDerivative · entry 2 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,827 Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 232 | $69.84 | $16,203.85 |
DisclosureSEC source: 0001214659-26-007315 · marketforms-73370.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,954 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 800 | $62.48 | $49,987.20 |
DisclosureSEC source: 0001214659-26-006834 · marketforms-73278.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,186 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 21, 2026 Filed May 26, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 688 | $53.26 | $36,640.82 |
DisclosureSEC source: 0001214659-26-006714 · marketforms-73246.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,986 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 08, 2026 Filed May 12, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,961 | $56.88 | $282,186.64 |
DisclosureSEC source: 0001214659-26-005987 · marketforms-73147.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,674 Read SEC document |
| May 04, 2026 Filed May 6, 2026 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 164 | $57.15 | $9,372.40 |
DisclosureSEC source: 0001214659-26-005672 · marketforms-73058.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,635 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:06 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 246 | $46.43 | $11,420.80 |
DisclosureSEC source: 0001214659-26-003067 · marketforms-72449.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,799 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,693 | $46.71 | $79,079.69 |
DisclosureSEC source: 0001214659-26-002443 · marketforms-72312.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,045 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-26-001492 · marketforms-72079.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,738 F1 · shares: Represents a bona fide gift of shares to a charitable organization. Read SEC document |
| February 04, 2026 Filed Feb 5, 2026 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,000 | $45.65 | $319,536.00 |
DisclosureSEC source: 0001214659-26-001239 · marketforms-72018.xml · nonDerivative · entry 2 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,738 F2 · shares: Represents the weighted average sales price per share. The shares sold at prices ranging from $45.61 to $45.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 175 | $46.58 | $8,150.80 |
DisclosureSEC source: 0001214659-26-001239 · marketforms-72018.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,738 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 230 | $32.88 | $7,561.94 |
DisclosureSEC source: 0001214659-25-017847 · marketforms-71491.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,913 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 822 | $28.71 | $23,599.21 |
DisclosureSEC source: 0001214659-25-017217 · marketforms-71347.xml · nonDerivative · entry 2 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,143 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 229 | $26.50 | $6,069.30 |
DisclosureSEC source: 0001214659-25-017217 · marketforms-71347.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,965 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 16,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-016997 · marketforms-71310.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,194 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2024 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 160 | $32.08 | $5,132.70 |
DisclosureSEC source: 0001214659-25-015970 · marketforms-71204.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,870 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,016 | $31.44 | $31,947.41 |
DisclosureSEC source: 0001214659-25-015762 · marketforms-71188.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,030 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 5,633 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-25-015588 · marketforms-71167.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,046 F1 · shares: Represents Performance Stock Units for which target criteria was determined to have been met on October 28, 2025. 60% of the PSUs remain subject to time-based vesting and will vest on October 1, 2026, subject to continued service or acceleration of vesting as provided in the award agreement. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,041 | $32.19 | $65,693.67 |
DisclosureSEC source: 0001214659-25-014775 · marketforms-70960.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,413 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 13:11 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 235 | $25.76 | $6,053.60 |
DisclosureSEC source: 0001214659-25-013565 · marketforms-70712.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,454 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 853 | $27.69 | $23,620.42 |
DisclosureSEC source: 0001214659-25-012894 · marketforms-70407.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,689 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 21, 2025 Filed Aug 25, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 238 | $25.96 | $6,179.43 |
DisclosureSEC source: 0001214659-25-012708 · marketforms-70342.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,542 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 04, 2025 Filed Aug 6, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 186 | $28.36 | $5,275.70 |
DisclosureSEC source: 0001214659-25-011611 · marketforms-70151.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,780 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 225 | $31.75 | $7,143.75 |
DisclosureSEC source: 0001214659-25-009060 · marketforms-69850.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,966 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 23, 2025 Filed May 28, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 839 | $27.73 | $23,263.79 |
DisclosureSEC source: 0001214659-25-008474 · marketforms-69675.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,191 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 242 | $29.75 | $7,198.77 |
DisclosureSEC source: 0001214659-25-008297 · marketforms-69633.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,030 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 05, 2025 Filed May 7, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 162 | $37.65 | $6,099.46 |
DisclosureSEC source: 0001214659-25-007100 · marketforms-69371.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,272 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 241 | $40.91 | $9,860.03 |
DisclosureSEC source: 0001214659-25-004110 · marketforms-68688.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,434 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 24, 2025 Filed Feb 25, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 916 | $41.71 | $38,209.11 |
DisclosureSEC source: 0001214659-25-003433 · marketforms-68345.xml · nonDerivative · entry 2 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,675 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 21, 2025 Filed Feb 25, 2025 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 267 | $44.18 | $11,795.26 |
DisclosureSEC source: 0001214659-25-003433 · marketforms-68345.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,591 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 21:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 185 | $49.35 | $9,130.12 |
DisclosureSEC source: 0001214659-25-002010 · marketforms-67971.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,858 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 226 | $52.70 | $11,911.10 |
DisclosureSEC source: 0001214659-24-020170 · marketforms-67537.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,043 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 8,438 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-020028 · marketforms-67499.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,269 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of November 20, 2024 for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 789 | $44.20 | $34,870.64 |
DisclosureSEC source: 0001214659-24-019679 · marketforms-67437.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,831 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 06, 2024 Filed Nov 8, 2024 21:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,448 | $44.61 | $64,588.04 |
DisclosureSEC source: 0001214659-24-018615 · marketforms-67294.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,620 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Performance Stock Units ("PSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| November 06, 2024 Filed Nov 15, 2024 21:05 UTC Amendment | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,448 | $44.61 | $64,588.04 |
DisclosureSEC source: 0001214659-24-019253 · marketforms-67369.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,620 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Performance Stock Units ("PSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 156 | $41.56 | $6,483.98 |
DisclosureSEC source: 0001214659-24-018497 · marketforms-67273.xml · nonDerivative · entry 2 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,068 F2 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 22:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 8,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-24-018497 · marketforms-67273.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,224 F1 · shares: Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 20:03 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 240 | $39.16 | $9,398.64 |
DisclosureSEC source: 0001214659-24-016290 · marketforms-66950.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,724 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 813 | $43.14 | $35,074.45 |
DisclosureSEC source: 0001214659-24-015371 · marketforms-66847.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,964 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 168 | $39.93 | $6,707.57 |
DisclosureSEC source: 0001214659-24-014029 · marketforms-66738.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,777 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 242 | $51.33 | $12,421.62 |
DisclosureSEC source: 0001214659-24-010748 · marketforms-66287.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,945 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 23, 2024 Filed May 28, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,361 | $42.32 | $142,244.24 |
DisclosureSEC source: 0001214659-24-010040 · marketforms-66036.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,187 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| May 03, 2024 Filed May 7, 2024 20:05 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 132 | $37.13 | $4,901.69 |
DisclosureSEC source: 0001214659-24-008521 · marketforms-65758.xml · nonDerivative · entry 1 WERNER ROBERT F. · CIK 0001590947 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,548 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.